Loeillot Olivier
Chief Executive Officer
Loeillot Olivier has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Sep 8, 2026.
On the most recent filing, Loeillot Olivier is listed as Chief Executive Officer at REPLIGEN CORP. Inside the rolling window, Loeillot Olivier reported no open-market purchases and 4 open-market sales totaling $3.2M in RGEN. The largest disclosed transaction in the window is a sale of 7,041 RGEN shares on Nov 25, 2025, worth $1.2M.
Companies traded
Other insiders at RGEN
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.2M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Loeillot Olivier made?
Loeillot Olivier has filed 8 SEC Form 4 filings (11 transaction rows) across 1 company since 2025.
Which companies does Loeillot Olivier trade?
Loeillot Olivier has filed SEC Form 4 disclosures for 1 company, including RGEN.
When was Loeillot Olivier's most recent SEC Form 4 filing?
Loeillot Olivier's most recent SEC Form 4 filing on Tracefour is dated Sep 8, 2026.
What is Loeillot Olivier's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Loeillot Olivier is listed as Chief Executive Officer.
What is Loeillot Olivier's total buy and sell value in the current window?
Inside the rolling retention window, Loeillot Olivier bought $0 and sold $3.2M based on SEC Form 4 filings.
What was Loeillot Olivier's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 7,041 RGEN shares on 2025-11-25, worth $1.2M, per SEC Form 4 filings.